Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis

Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers

(2019) Saumitra V. Rege et al.   DRUG AND ALCOHOL DEPENDENCE

Refractory dependence on opioid analgesics

(2019) Jane C. Ballantyne et al.   PAIN

Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials

(2018) L.D. White et al.   BRITISH JOURNAL OF ANAESTHESIA

Alcohol and Opioid Use in Chronic Pain: A Cross-Sectional Examination of Differences in Functioning Based on Misuse Status

(2018) Kevin E. Vowles et al.   JOURNAL OF PAIN

Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics

(2018) Igor Bazov et al.   MOLECULAR NEUROBIOLOGY

Prevalence and Profile of High-Impact Chronic Pain in the United States

(2018) Mark H. Pitcher et al.   JOURNAL OF PAIN

Side Effect Rates of Opioids in Equianalgesic Doses Via Intravenous Patient-Controlled Analgesia

(2018) Hanns-Christian Dinges et al.   ANESTHESIA AND ANALGESIA

Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids

(2017) Martin Hale et al.   Journal of Pain Research

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain

(2016) Joseph Gimbel et al.   PAIN

Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.

(2015) Matthew J. Worley et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

Report of the NIH Task Force on Research Standards for Chronic Low Back Pain

(2015) R. A. Deyo et al.   PHYSICAL THERAPY

Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain

(2015) Richard L. Rauck et al.   POSTGRADUATE MEDICINE

A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression

(2015) Aaron Yarlas et al.   Pain Practice

Cost Burden of Chronic Pain Patients in a Large Integrated Delivery System in the United States

(2015) Peter W. Park et al.   Pain Practice

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Buprenorphine–Naloxone Therapy in Pain Management

(2014) Kelly Yan Chen et al.   ANESTHESIOLOGY

The clinical analgesic efficacy of buprenorphine

(2014) R. B. Raffa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Development of κ Opioid Receptor Antagonists

(2013) F. Ivy Carroll et al.   JOURNAL OF MEDICINAL CHEMISTRY

Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain

(2011) Tara Gomes et al.   ARCHIVES OF INTERNAL MEDICINE

A population-based survey of chronic pain and its treatment with prescription drugs

(2011) Robin L. Toblin et al.   PAIN

Transdermal Buprenorphine in Non-Oncological Moderate-to-Severe Chronic Pain

(2010) Antonio Gatti et al.   CLINICAL DRUG INVESTIGATION

Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase

(2010) Allan Gordon et al.   CLINICAL THERAPEUTICS

A Randomized, Double-Blind, Double-Dummy Comparison of the Efficacy and Tolerability of Low-Dose Transdermal Buprenorphine (BuTrans® Seven-Day Patches) With Buprenorphine Sublingual Tablets (Temgesic®) in Patients With Osteoarthritis Pain

(2010) Ian G.V. James et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study

(2009) Mats Karlsson et al.   CLINICAL THERAPEUTICS

Opioids and the treatment of chronic pain: Controversies, current status, and future directions.

(2008) Andrew Rosenblum et al.   EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY